A Phase 1b randomized, double-blind, crossover, placebo-controlled study evaluating the safety, tolerability and efficacy of IMB-115 in patients with insomnia disorder

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 02 Sep 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

02 Sep 2020 New trial record
28 Aug 2020 According to an Imbrium Therapeutics media release, data from this study were shared in an oral presentation and a poster at the 34th Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2020).
28 Aug 2020 Results published in the Imbrium Therapeutics Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com